Sandra A. Gardiner's Net Worth
$275 Thousand
Who is Sandra A. Gardiner?
Sandra A. Gardiner does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include CUTERA INC, VERMILLION, INC., Pulse Biosciences, Inc., Lucira Health, Inc., NEKTAR THERAPEUTICS, Anebulo Pharmaceuticals, Inc., Kronos Bio, Inc., and LIPID SCIENCES INC/.
SEC CIK
Sandra A. Gardiner's CIK is 0001218574
Past Insider Trading and Trends
2019 was Sandra A. Gardiner's most active year for acquiring shares with 4 total transactions. Sandra A. Gardiner's most active month to acquire stocks was the month of January. 2007 was Sandra A. Gardiner's most active year for disposing of shares, totalling 6 transactions. Sandra A. Gardiner's most active month to dispose stocks was the month of November. 2005 saw Sandra A. Gardiner paying a total of $128,552.80 for 34,744 shares, this is the most they've acquired in one year. In 2019 Sandra A. Gardiner cashed out on 1,676 shares for a total of $28,525.52, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
CUTERA INC (CUTR) Snapshot price: $2.785
EVP & Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +139.09% | 18.13K |
—
|
—
| 31.16K |
Feb 12
| |||
Form 4
| +8.84% | 1.06K |
$17.02 | -$28,525.52 | 13.03K |
Jan 2
| |||
Form 4
| -5.55% | -704.00 |
$16.52 | -$11,630.08 | 11.97K |
Dec 15
| |||
Form 4
| -3.37% | -442.00 |
$20.50 | -$9,061.00 | 12.68K |
Dec 1
| |||
Form 4
| +76.41% | 5.47K |
—
|
—
| 12.63K |
Feb 13
| |||
Form 4
|
∞
| 7.16K |
—
|
—
| 7.16K |
Dec 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
VERMILLION, INC. (AWH) Snapshot price: $4.31
VP & Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 24K |
—
|
—
| 24K |
Mar 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 24
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Pulse Biosciences, Inc. (PLSE) Snapshot price: $8.56
CFO & EVP Admin. and Finance
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 9 - Mar 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 18
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Lucira Health, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
NEKTAR THERAPEUTICS (NKTR) Snapshot price: $0.7
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||